ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.665
+0.175 (7.03%)
May 15, 2025, 1:50 PM - Market open

ImmunityBio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Cash & Equivalents
60.66143.43265.45104.64181.134.92
Upgrade
Short-Term Investments
0.936.381.012.54136.0261.15
Upgrade
Cash & Short-Term Investments
61.59149.81266.46107.18317.1296.06
Upgrade
Cash Growth
-63.88%-43.78%148.60%-66.20%230.12%49.28%
Upgrade
Accounts Receivable
17.032.36----
Upgrade
Other Receivables
0.420.293.171.891.332
Upgrade
Receivables
17.452.653.171.891.332
Upgrade
Inventory
8.448.27-2.16--
Upgrade
Prepaid Expenses
13.6216.7313.9814.7412.2513.65
Upgrade
Other Current Assets
8.057.1210.4714.63.65-
Upgrade
Total Current Assets
109.16184.59294.08140.58334.35111.71
Upgrade
Property, Plant & Equipment
167.05170.46182.68189.58119.1790.68
Upgrade
Long-Term Investments
0.7-0.890.847.611.4
Upgrade
Goodwill
0.910.91----
Upgrade
Other Intangible Assets
14.5315.0217.09201.421.46
Upgrade
Other Long-Term Assets
4.214.832.824.73--
Upgrade
Total Assets
303.76382.93504.45362.36468.91221.38
Upgrade
Accounts Payable
13.56.739.221.0211.4211.51
Upgrade
Accrued Expenses
25.5937.9139.5334.2333.9433.99
Upgrade
Short-Term Debt
-1.251.48433.32301.83-
Upgrade
Current Portion of Leases
7.467.475.312.733.015.02
Upgrade
Other Current Liabilities
2.661.62.779.5718.817.62
Upgrade
Total Current Liabilities
49.2154.9458.28500.8636968.13
Upgrade
Long-Term Debt
782746.28836.95241.27306.35254.35
Upgrade
Long-Term Leases
33.134.8239.9448.0237.0716.18
Upgrade
Long-Term Deferred Tax Liabilities
-----0.17
Upgrade
Other Long-Term Liabilities
29.9435.01155.2122.030.411.04
Upgrade
Total Liabilities
894.24871.061,090812.18712.82339.87
Upgrade
Common Stock
0.090.090.070.040.040.04
Upgrade
Additional Paid-In Capital
2,8932,8852,3751,9311,7201,495
Upgrade
Retained Earnings
-3,505-3,375-2,962-2,378-1,962-1,615
Upgrade
Comprehensive Income & Other
19.961.20.010.1800.12
Upgrade
Total Common Equity
-591.43-489.1-586.99-447.33-242.17-119.81
Upgrade
Minority Interest
0.950.971.05-2.49-1.741.32
Upgrade
Shareholders' Equity
-590.48-488.13-585.94-449.82-243.91-118.49
Upgrade
Total Liabilities & Equity
303.76382.93504.45362.36468.91221.38
Upgrade
Total Debt
822.56789.82883.68725.33648.26275.55
Upgrade
Net Cash (Debt)
-760.97-640.01-616.32-617.31-330.32-178.54
Upgrade
Net Cash Per Share
-1.03-0.91-1.21-1.54-0.85-0.47
Upgrade
Filing Date Shares Outstanding
882.62853.44673.95435.84397.91333.96
Upgrade
Total Common Shares Outstanding
853.56852.9670.87421.57397.83333.96
Upgrade
Working Capital
59.96129.64235.8-360.28-34.6543.58
Upgrade
Book Value Per Share
-0.69-0.57-0.87-1.06-0.61-0.36
Upgrade
Tangible Book Value
-606.87-505.03-604.08-467.33-243.59-121.27
Upgrade
Tangible Book Value Per Share
-0.71-0.59-0.90-1.11-0.61-0.36
Upgrade
Buildings
-----22.69
Upgrade
Machinery
76.875.4471.869.8555.3435.75
Upgrade
Construction In Progress
86.4386.4284.4472.6916.581.33
Upgrade
Leasehold Improvements
73.2873.1372.5568.7162.4852.25
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q